advertisement
Xu X 42
Showing records 1 to 25 | Display all abstracts from Xu X113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Wang H
Advances in ophthalmology practice and research 2023; 3: 159-170
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Wu J
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
He C; Xiu W
Science translational medicine 2023; 15: eadg1656
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Fang H
Medical Image Analysis 2023; 90: 102938
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Ye Q
Advances in ophthalmology practice and research 2023; 3: 159-170
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Li F
Medical Image Analysis 2023; 90: 102938
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Xu W
Advances in ophthalmology practice and research 2023; 3: 159-170
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Chen Q; Peng K
Science translational medicine 2023; 15: eadg1656
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Fu H
Medical Image Analysis 2023; 90: 102938
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Wang J
Advances in ophthalmology practice and research 2023; 3: 159-170
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Lin F
Medical Image Analysis 2023; 90: 102938
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Liu J
Advances in ophthalmology practice and research 2023; 3: 159-170
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Zhu X
Science translational medicine 2023; 15: eadg1656
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Xu X
Advances in ophthalmology practice and research 2023; 3: 159-170
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Li J
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Xu X
Science translational medicine 2023; 15: eadg1656
113011 Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study
Zhang W
Advances in ophthalmology practice and research 2023; 3: 159-170
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Huang Y; Yu Q
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Zhang G
Science translational medicine 2023; 15: eadg1656
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Song S; Xu X
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Fu J
Science translational medicine 2023; 15: eadg1656
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Xu Y
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Dong Q; Wu X
Science translational medicine 2023; 15: eadg1656
111918 GAMMA challenge: Glaucoma grAding from Multi-Modality imAges
Wang W; Wang L
Medical Image Analysis 2023; 90: 102938
111771 Gut-licensed β7 CD4 T cells contribute to progressive retinal ganglion cell damage in glaucoma
Li A
Science translational medicine 2023; 15: eadg1656
